Tue, February 18, 2020
Fri, February 14, 2020
Thu, February 13, 2020
Wed, February 12, 2020
Tue, February 11, 2020
Mon, February 10, 2020
Sun, February 9, 2020
Fri, February 7, 2020
Thu, February 6, 2020
Wed, February 5, 2020

Christopher Marai Maintained (ALNY) at Sell with Increased Target to $75 on, Feb 11th, 2020

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-75-on-feb-11th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

- Click to Lock Slider
Christopher Marai of Nomura, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Sell with Increased Target from $62 to $75 on, Feb 11th, 2020.

Christopher has made no other calls on ALNY in the last 4 months.



There are 5 other peers that have a rating on ALNY. Out of the 5 peers that are also analyzing ALNY, 0 agree with Christopher's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Christopher


  • David Lebovitz of "Morgan Stanley" Maintained at Buy with Decreased Target to $148 on, Friday, February 7th, 2020
  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy with Increased Target to $190 on, Thursday, December 19th, 2019
  • Olivia Brayer of "Cantor Fitzgerald" Reiterated at Buy with Increased Target to $176 on, Wednesday, December 18th, 2019
  • Do Kim of "BMO Capital" Maintained at Buy with Increased Target to $143 on, Monday, November 25th, 2019
  • Leland Gershell of "Oppenheimer" Initiated at Buy and Held Target at $128 on, Wednesday, November 20th, 2019